Managers
Brentwood Associates (Brentwood), a Los Angeles-based private equity firm, has closed the Brentwood Associates Opportunities Fund, with USD190 million in capital commitments.
The fund has has completed the purchase of selected legacy assets from two of Brentwood’s prior funds and provided liquidity to its investors.
The transaction, which was led by Spring Bridge Partners, with significant backing from Hollyport Capital and other institutional investors, provides capital and additional flexibility to support the growth of the portfolio companies included in the transaction.
“We are excited to partner with these highly respected and experienced institutional investors in a structured transaction that allows
&vest, an investment platform founded in 2019 focused on SPACs and private investments, has appointed Bill Hinman as a Partner.
Hinman served as Director of Corporation Finance at the US Securities and Exchange Commission (SEC) from 2017 to 2020, where he was primarily responsible for overseeing regulations and processes for initial public offerings and other corporate disclosures. During his tenure at the SEC, Mr. Hinman spearheaded nearly 50 policy and rule-making initiatives designed to strengthen public markets as well as modernise and improve the framework for companies accessing capital markets, including addressing the large increase in SPAC offerings.
Prior to
Queen’s Park Equity (QPE) has supported the management buyout of Sagacity Solutions (Sagacity), a provider of tech-enabled customer data management solutions, led by the founders of the business, Anita Dougall, Malka Townshend and Harry Dougall.
Sagacity offers three core solutions within the lifecycle of its clients’ customers; reducing bad debt, improving revenue & margin and optimising customer value. Sagacity generates impressive ROI for some of the largest utility, telecoms and financial services corporates and is very well positioned to capitalise on the multi-million UK market opportunity. QPE is investing alongside the founders to support the company’s continued expansion.
Nordic Capital, a private equity investor with a resolute commitment to creating stronger, sustainable businesses, has further invested in ArisGlobal, by acquiring an additional shareholding from the founding Abbhi family.
The transaction follows Nordic Capital’s initial investment in ArisGlobal, a provider of innovative software-as-a-service (SaaS) solutions for the life sciences industry in 2019 and subsequent years of significant growth for the Miami-based company. Drawing on its deep understanding of both the healthcare and technology sectors, Nordic Capital will continue to support ArisGlobal’s growth, with further investment into research and development, cognitive computing, global delivery and commercial operations.
ArisGlobal
Hayden AI Technologies, Inc (Hayden AI), a smart city solutions provider, has closed a USD4.5 million funding round led by BootstrapLabs, an early-stage Silicon Valley venture capital firm focused on Applied Artificial Intelligence.
This brings the company’s total funding to USD9.5 million, including a USD5 million seed round from last year. The new funding will go towards accelerating the development and delivery of AI-powered solutions aimed at enabling governments to achieve their goals of safer streets, equitable transportation, and efficient urban mobility.
In addition to BootstrapLabs also participating in the round were seed stage investor MVP Partners, UC Berkeley’s
Concentrix Corporation, a global provider of customer experience (CX) solutions and technology, has reached a definitive agreement to sell its insurance third-party administration operations and software platform (CIS) to Abry Partners, a Boston-based private equity firm, and Hoplon Capital, an asset manager focused on digital disruption of end markets including insurance.
This will create a new company which will operate as a standalone business bringing innovation to the insurance marketplace. The transaction is expected to close by the end of May 2021 subject to the approval of customary regulatory requirements and closing conditions. The sale does not impact Concentrix’
Arkhn, a specialist in healthcare data interoperability, has finalised a first round of financing of EUR4 million. This financing round was jointly led by Kurma Partners and Newfund, through their respective funds Kurma Diagnostics II and Newfund II, with the support of the European Commission and the public bank Bpifrance.
Founded in August 2019, Arkhn tackles the issue of accessing healthcare data. It has become critical for care facilities and the entire healthcare ecosystem: medical teams, public and private researchers, patients, medical startups and softwares. This imperative need for data sovereignty has been highlighted by the coronavirus crisis and by
An affiliate HIG Capital (HIG) has completed a USD225 million strategic minority investment in eHealth, in the form of convertible preferred stock.
Headquartered in Santa Clara, California, eHealth operates a leading online marketplace offering consumers a broad choice of insurance products that includes thousands of Medicare Advantage, Medicare Supplement, Medicare Part D plans, individual and family health insurance, small business insurance and ancillary health insurance products from over 180 health insurance carriers.
Scott Flanders, Chief Executive Officer of eHealth, says: “We are excited to team up with HIG as we grow scale and market share by helping millions of Americans
Global law firm White & Case LLP has advised US investment firm Narrative Capital on its acquisition of Sony Pictures Television’s entire UK channels portfolio.
“This is an exciting time for the media industry and we are looking forward to continuing to work with the Narrative team to build its global business,” says White & Case partner Daniel Turgel, co-head of the Firm’s Global Technology Industry Group, who co-led the deal team.
The transaction includes Sony’s seven free-to-air channels including Sony Movies, Sony Movies Action, Sony Movies Classic, Sony Channel, POP, Tiny POP and POP Max, as well as
Summa Equity is to sell HyTest, a developer and producer of antibodies and antigens, to Mindray, a global medical technology company, for total consideration of approximately EUR545 million.
Since Summa Equity’s acquisition of HyTest in 2018, the company has continued to develop its industry leading antibodies and antigens product portfolio, maintaining and growing market leading positions in several key segments, including cardiac markers, inflammation and infectious diseases. HyTest’s products cover over 20 disease groups and yearly provides antibodies and antigens for in vitro diagnostic (IVD) tests run on over 300 million patients globally. The company contributes to improve UN Sustainable
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
